Search For "commercialisation of trastuzumab and insulin glargine"
Biocon's Biologics drug products facility gets nod from US FDA
Updated : 6 years, 9 months ago IST
Bengaluru (Karnataka) [India], Nov 5 (ANI): Biopharmaceuticals major Biocon Ltd said on Tuesday it has received an establishment inspection report from the US Food and Drug Administration (FDA) for its biologics drug product facility here, reaffirming its global scale manufacturing capabilit
Read More